Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 100/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Tranexamic acid is a derivative of aminomethylbenzoic acid, and a kind of antifibrinolytic drugs to stop bleeding. The hemostasis mechanism of tranexamic acid is similar to aminocaproic acid and aminomethylbenzoic acid, but the effect is stronger. The strength is 7 to 10 times of aminocaproic acid, 2 times of aminomethylbenzoic acid, but toxicity is similar.
The chemical structure of tranexamic acid is similar to lysine, competitive inhibition of plasmin original in fibrin adsorption, to prevent their activation, protection fiber protein not to degrade by plasmin and dissolve, eventually achieve hemostasis. Applicable in the treatment of acute or chronic, localized or systemic primary fiber fibrinolytic hyperthyroidism caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hemorrhage of hypertrophy of the prostate, hemophilia, pulmonary tuberculosis hemoptysis, stomach bleeding, after operation of liver, lung, spleen and other viscera hemorrhage; also can be used in surgery when abnormal bleeding etc..
Analysi | Specifications | |
Assay | ≥99% | |
Appearance | White | |
Loss on Drying | ≤1.0% | |
Ash | ≤1.0% | |
As | ≤2.0ppm | |
Pb | ≤2.0ppm | |
Insoluble impurity content | ≤0.05% | |
Total Plate Count | ≤1000 cfu/g | |
Yeast &. Mold | ≤100 cfu/g | |
E.Coli | Negative | |
Salmonella | Negative | |
Conclusion |
Conform USP Standard.
|
|
Storage condition |
Store in cool & dry place, Keep away from strong light and heat.
|
|
Shelf life |
2 years when properly stored.
|